Advertisement
Screener

PALATIN TECHNOLOGIES, INC. (PTN) Payments for Repurchase of Warrants

2.0 / 5 stars · 28/71 Roast Me

PALATIN TECHNOLOGIES, INC. Payments for Repurchase of Warrants

Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).

  • PALATIN TECHNOLOGIES, INC. payments for repurchase of warrants for the quarter ending 2021-03-31 was $0.00.
  • PALATIN TECHNOLOGIES, INC. payments for repurchase of warrants for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
  • PALATIN TECHNOLOGIES, INC. payments for repurchase of warrants for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
  • PALATIN TECHNOLOGIES, INC. payments for repurchase of warrants for the quarter ending 2020-03-31 was $0.00.
Period endPayments for Repurchase of Warrants 3 monthPayments for Repurchase of Warrants 12 month
2021-03-31$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-14
2020-12-31$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-16
2020-09-30$0.00
10-Q · filed 2020-11-16
2020-03-31$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-14
2019-12-31$1.21M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-16
2019-09-30$1.33M
10-Q · filed 2020-11-16
2019-03-31$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-11
2018-12-31$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-10
2018-09-30$0.00
10-Q · filed 2019-11-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lipocine Inc. (LPCN)United States$0.017B-1.79
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81
Biofrontera Inc. (BFRI)United States$0.018B-2.13
Korsana Biosciences, Inc. (CYCN)United States$0.016B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
Rocket One Inc. (RKTO)United States$0.019B
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)United States$0.019B-0.31
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B